Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.

Pantziarka P, Hutchinson L, André N, Benzekry S, Bertolini F, Bhattacharjee A, Chiplunkar S, Duda DG, Gota V, Gupta S, Joshi A, Kannan S, Kerbel R, Kieran M, Palazzo A, Parikh A, Pasquier E, Patil V, Prabhash K, Shaked Y, Sholler GS, Sterba J, Waxman DJ, Banavali S.

Ecancermedicalscience. 2016 Nov 2;10:689.

2.

Intracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release Mechanism.

Petrou T, Olsen HL, Thrasivoulou C, Masters JR, Ashmore JF, Ahmed A.

J Pharmacol Exp Ther. 2017 Feb;360(2):378-387. doi: 10.1124/jpet.116.236695.

3.

Prognostic significance of β2-adrenergic receptor expression in non-small cell lung cancer.

Yazawa T, Kaira K, Shimizu K, Shimizu A, Mori K, Nagashima T, Ohtaki Y, Oyama T, Mogi A, Kuwano H.

Am J Transl Res. 2016 Nov 15;8(11):5059-5070.

4.

Cancer cells become less deformable and more invasive with activation of β-adrenergic signaling.

Kim TH, Gill NK, Nyberg KD, Nguyen AV, Hohlbauch SV, Geisse NA, Nowell CJ, Sloan EK, Rowat AC.

J Cell Sci. 2016 Dec 15;129(24):4563-4575.

PMID:
27875276
5.
6.

The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review.

Hefner J, Csef H.

Geburtshilfe Frauenheilkd. 2016 Oct;76(10):1050-1056. Review.

7.

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.

Hwa YL, Shi Q, Kumar SK, Lacy MQ, Gertz MA, Kapoor P, Buadi FK, Leung N, Dingli D, Go RS, Hayman SR, Gonsalves WI, Russell S, Lust JA, Lin Y, Rajkumar SV, Dispenzieri A.

Am J Hematol. 2017 Jan;92(1):50-55. doi: 10.1002/ajh.24582.

8.

Long-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and Perspectives.

Riedel B, Sloan E, Forget P.

Int Anesthesiol Clin. 2016 Fall;54(4):58-71. doi: 10.1097/AIA.0000000000000111. No abstract available.

PMID:
27648891
9.

Neural regulation of cancer: from mechanobiology to inflammation.

Kim TH, Rowat AC, Sloan EK.

Clin Transl Immunology. 2016 May 13;5(5):e78. doi: 10.1038/cti.2016.18. Review.

10.

Role of the autonomic nervous system in tumorigenesis and metastasis.

Magnon C.

Mol Cell Oncol. 2015 Feb 25;2(2):e975643. doi: 10.4161/23723556.2014.975643. Review.

11.

Prevention of pancreatic cancer in a hamster model by cAMP decrease.

Banerjee J, Papu John AM, Al-Wadei MH, Schuller HM.

Oncotarget. 2016 Jul 12;7(28):44430-44441. doi: 10.18632/oncotarget.9790.

12.

The Bone Microenvironment: a Fertile Soil for Tumor Growth.

Buenrostro D, Mulcrone PL, Owens P, Sterling JA.

Curr Osteoporos Rep. 2016 Aug;14(4):151-8. doi: 10.1007/s11914-016-0315-2. Review.

PMID:
27255469
13.

Breast cancer and social environment: getting by with a little help from our friends.

Hinzey A, Gaudier-Diaz MM, Lustberg MB, DeVries AC.

Breast Cancer Res. 2016 May 26;18(1):54. doi: 10.1186/s13058-016-0700-x. Review.

14.

Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.

Choy C, Raytis JL, Smith DD, Duenas M, Neman J, Jandial R, Lew MW.

Oncol Rep. 2016 Jun;35(6):3135-42. doi: 10.3892/or.2016.4710.

15.

Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.

Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H, Pimentel MA, Chai MG, Karnezis T, Rotmensz N, Renne G, Gandini S, Pouton CW, Ferrari D, Möller A, Stacker SA, Sloan EK.

Nat Commun. 2016 Mar 1;7:10634. doi: 10.1038/ncomms10634.

16.

Re-Use of Established Drugs for Anti-Metastatic Indications.

Entschladen F, Thyssen DA, Drell DW.

Cells. 2016 Jan 12;5(1). pii: E2. doi: 10.3390/cells5010002. Review.

17.

Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.

Sysa-Shah P, Tocchetti CG, Gupta M, Rainer PP, Shen X, Kang BH, Belmonte F, Li J, Xu Y, Guo X, Bedja D, Gao WD, Paolocci N, Rath R, Sawyer DB, Naga Prasad SV, Gabrielson K.

Cardiovasc Res. 2016 Mar 1;109(3):358-73. doi: 10.1093/cvr/cvv274.

18.

β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion.

Creed SJ, Le CP, Hassan M, Pon CK, Albold S, Chan KT, Berginski ME, Huang Z, Bear JE, Lane JR, Halls ML, Ferrari D, Nowell CJ, Sloan EK.

Breast Cancer Res. 2015 Nov 25;17(1):145. doi: 10.1186/s13058-015-0655-3.

19.

Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.

Kang Y, Nagaraja AS, Armaiz-Pena GN, Dorniak PL, Hu W, Rupaimoole R, Liu T, Gharpure KM, Previs RA, Hansen JM, Rodriguez-Aguayo C, Ivan C, Ram P, Sehgal V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK.

Clin Cancer Res. 2016 Apr 1;22(7):1713-24. doi: 10.1158/1078-0432.CCR-15-1275.

PMID:
26581245
20.

The β2-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion.

Pon CK, Lane JR, Sloan EK, Halls ML.

FASEB J. 2016 Mar;30(3):1144-54. doi: 10.1096/fj.15-277798.

Supplemental Content

Support Center